NCT00836602View on ClinicalTrials.gov

Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Atherosclerosis
Interventions
DRUG

BMS-779788

Oral Solution, Oral, 1 mg, Once daily, 7 days

DRUG

BMS-779788

Oral Solution, Oral, 2 mg, Once daily, 7 days

DRUG

BMS-779788

Oral Solution, Oral, \<= 4 mg, Once daily, 7 days

DRUG

Placebo

Oral Solution, Oral, 0 mg, Once daily, 7 days

Trial Locations (1)

3084

Local Institution, Heidelberg

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00836602 - Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects | Biotech Hunter | Biotech Hunter